Aptus Capital Advisors’s Alpha Tau Medical DRTS Stock Holding History

Aptus Capital Advisors’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$141K	Sell	20,000 -1,945	-9%	-$13.7K	﹤0.01%	1075
2025 Q4	$109K	Hold	21,945	–	–	﹤0.01%	1162
2025 Q3	$99K	Hold	21,945	–	–	﹤0.01%	1123
2025 Q2	$68.5K	Hold	21,945	–	–	﹤0.01%	1132
2025 Q1	$55.1K	Hold	21,945	–	–	﹤0.01%	1096
2024 Q4	$68K	Hold	21,945	–	–	﹤0.01%	1063
2024 Q3	$52.2K	Hold	21,945	–	–	﹤0.01%	931
2024 Q2	$55.5K	Buy	21,945 +10,000	+84%	+$25.4K	﹤0.01%	880
2024 Q1	$35.2K	Buy	+11,945	New	+$36.7K	﹤0.01%	926

Other funds holding DRTS

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Aptus Capital Advisors's DRTS Position: Q1 2026 in Review

Aptus Capital Advisors reduced its Alpha Tau Medical (DRTS) stake by 8.9% in Q1 2026, selling an estimated $13.7K and leaving 20,000 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #1075.

Aptus Capital Advisors first reported a position in DRTS in Q1 2024 and has held it in 9 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

Aptus Capital Advisors held 20,000 shares of Alpha Tau Medical worth $141K as of Q1 2026.
Aptus Capital Advisors sold 1,945 Alpha Tau Medical shares in Q1 2026, an estimated $13.7K.
Alpha Tau Medical made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q1 2026, its #1075 holding.
Aptus Capital Advisors first reported a position in Alpha Tau Medical in Q1 2024 and has held it in 9 quarters since.
53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.